ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $46,718,000 | +220.5% | 2,477,066 | +100.0% | 0.34% | +56.8% |
| Q2 2019 | $14,578,000 | -13.8% | 1,238,533 | 0.0% | 0.22% | -33.7% |
| Q1 2019 | $16,906,000 | +33.2% | 1,238,533 | 0.0% | 0.33% | +62.0% |
| Q4 2018 | $12,695,000 | -38.4% | 1,238,533 | 0.0% | 0.20% | -21.8% |
| Q3 2018 | $20,622,000 | +5.4% | 1,238,533 | 0.0% | 0.26% | +1.9% |
| Q2 2018 | $19,569,000 | +24.4% | 1,238,533 | 0.0% | 0.26% | +8.4% |
| Q1 2018 | $15,729,000 | +10.9% | 1,238,533 | 0.0% | 0.24% | +8.7% |
| Q4 2017 | $14,181,000 | -6.5% | 1,238,533 | 0.0% | 0.22% | -11.4% |
| Q3 2017 | $15,172,000 | +7.0% | 1,238,533 | 0.0% | 0.25% | +27.5% |
| Q2 2017 | $14,181,000 | -45.0% | 1,238,533 | 0.0% | 0.19% | -37.9% |
| Q1 2017 | $25,761,000 | 0.0% | 1,238,533 | 0.0% | 0.31% | +11.9% |
| Q4 2016 | $25,761,000 | -36.5% | 1,238,533 | 0.0% | 0.28% | -32.2% |
| Q3 2016 | $40,587,000 | +31.2% | 1,238,533 | 0.0% | 0.41% | +20.9% |
| Q2 2016 | $30,926,000 | +2.0% | 1,238,533 | 0.0% | 0.34% | +12.6% |
| Q1 2016 | $30,332,000 | -25.9% | 1,238,533 | 0.0% | 0.30% | +1.7% |
| Q4 2015 | $40,909,000 | +0.8% | 1,238,533 | 0.0% | 0.30% | +51.0% |
| Q3 2015 | $40,574,000 | -38.2% | 1,238,533 | 0.0% | 0.20% | -35.3% |
| Q2 2015 | $65,605,000 | -8.7% | 1,238,533 | -50.2% | 0.30% | -16.5% |
| Q1 2015 | $71,819,000 | – | 2,488,533 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,130 | $40,160,000 | 10.45% |
| Foresite Capital Management II, LLC | 1,586,220 | $21,652,000 | 9.78% |
| DAFNA Capital Management LLC | 571,013 | $7,794,000 | 3.36% |
| Redmile Group, LLC | 8,244,896 | $112,543,000 | 3.29% |
| Lion Point Capital, LP | 1,271,500 | $17,355,000 | 1.57% |
| Palo Alto Investors LP | 1,861,630 | $25,411,000 | 1.06% |
| SAMLYN CAPITAL, LLC | 3,185,983 | $43,488,000 | 1.03% |
| Bellevue Group AG | 1,286,748 | $17,564,000 | 0.97% |
| BB BIOTECH AG | 2,766,008 | $37,756,000 | 0.95% |
| Rock Springs Capital Management LP | 1,560,000 | $21,294,000 | 0.82% |